Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 6,543 | 27 | 16 | 7 | 5 |
| Cost of Goods | 11 | 22 | 13 | 5 | 4 |
| Gross Profit | 6,532 | 5 | 3 | 1 | 1 |
| Operating Expenses | 3,307 | 4,468 | 3,308 | 3,471 | 1,971 |
| Operating Income | 3,236 | -4,441 | -3,292 | -3,464 | -1,966 |
| Interest Expense | 109 | 233 | 127 | 229 | 256 |
| Other Income | 676 | 5,393 | -1,135 | 1,765 | 25 |
| Pre-tax Income | 3,803 | 719 | -4,554 | -1,928 | -2,197 |
| Income Tax | 330 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 3,473 | 719 | -4,554 | -1,928 | -2,197 |
| Net Income | $3,473 | $719 | $-4,554 | $-1,928 | $-2,197 |
| EPS Basic Total Ops | 0.37 | 0.15 | -2.02 | -6.79 | -1.97 |
| EPS Basic Continuous Ops | 0.64 | 1.27 | -2.02 | -1.08 | -1.97 |
| EPS Diluted Total Ops | 0.37 | 0.15 | -2.02 | -6.79 | -1.97 |
| EPS Diluted Continuous Ops | 0.64 | 1.27 | -2.02 | -1.08 | -1.97 |
| EPS Diluted Before Non-Recurring Items | 0.37 | -2.63 | -2.02 | -6.79 | -0.05 |
| EBITDA(a) | $3,378 | $-4,284 | $-3,118 | $-3,172 | $-1,547 |